Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 9, 2010, Pages 1556-1561

  Fan, Lifang ^a   Mac, Mylinh T ^a   Frishberg, David P ^a   Fan, Xuemo ^a   Dhall, Deepti ^a   Balzer, Bonnie L ^a   Geller, Stephen A ^a   Wang, Hanlin L ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

hepatocellular carcinoma; interobserver; intraobserver; vascular invasion

Indexed keywords

ARTICLE; BLOOD VESSEL; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CANCER SURGERY; HUMAN; HUMAN TISSUE; KAPPA STATISTICS; LIVER CELL CARCINOMA; LIVER RESECTION; OBSERVER VARIATION; PATHOLOGIST; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 77956022414     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06304.x     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J et al. Estimating the world cancer burden: globocan 2000. Int. J. Cancer. 2001 94 : 153 156.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999 340 : 745 750.
3. Greene FL, Page DL, Fleming ID et al. AJCC Cancer Staging Manual, 6th edn. Chicago, IL : Springer, 2002 131 138.
4. Okuda K, Ohtsuki T, Obata H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985 56 : 918 928.
5. The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998 28 : 751 755.
6. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan integrated staging score (JISscore). J. Gastroenterol. 2003 38 : 207 215.
7. Edge SB, Byrd DR, Compton CC et al. AJCC Cancer Staging Manual, 7th edn. Chicago, IL : Springer, 2010 191 199.
8. Vauthey JN, Lauwers GY, Esnaola NF et al. Simplified staging for hepatocellular carcinoma. J. Clin. Oncol. 2002 20 : 1527 1536.
9. Roayaie S, Frischer JS, Emre SH et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann. Surg. 2002 235 : 533 539.
10. Kikuchi LO, Paranaguá-Vezozzo DC, Chagas AL et al. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma. J. Clin. Gastroenterol. 2009 43 : 191 195.
11. Shah SA, Tan JC, McGilvray ID et al. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 2006 81 : 1633 1639.
12. Tsai TJ, Chau GY, Lui WY et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000 127 : 603 608.
13. Jonas S, Bechstein WO, Steinmuller T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001 33 : 1080 1086.
14. Lei HJ, Chau GY, Lui WY et al. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J. Am. Coll. Surg. 2006 203 : 426 435.
15. Kee KM, Wang JH, Lee CM et al. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int. J. Cancer 2007 120 : 2650 2655.
16. Pawlik TM, Delman KA, Vauthey JN et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005 11 : 1086 1092.
17. Cohen J. Coefficient of agreement for nominal scales. Educ. Psychol. Meas. 1960 120 : 37 46.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977 33 : 159 174.
19. Harris EI, Lewin DN, Wang HL et al. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am. J. Surg. Pathol. 2008 32 : 1816 1821.
20. Anderson TJ, Sufi F, Ellis IO et al. Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years. Hum. Pathol. 2002 33 : 365 371.
21. Gilchrist KW, Gould VE, Hirschl S et al. Interobserver variation in the identification of breast carcinoma in intramammary lymphatics. Hum. Pathol. 1982 13 : 170 172.
22. Orbo A, Stalsberg H, Kunde D. Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatics. Cancer 1990 66 : 972 977.
23. Franc B, de la Salmonière P, Lange F et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum. Pathol. 2003 34 : 1092 1100.
24. Ruck P, Xiao JC, Kaiserling E. Immunoreactivity of sinusoids in hepatocellular carcinoma: an immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. Arch. Pathol. Lab. Med. 1995 119 : 173 178.
25. Frachon S, Gouysse G, Dumortier J et al. Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. J. Hepatol. 2001 34 : 850 857.
26. Yang ZF, Poon RT. Vascular changes in hepatocellular carcinoma. Anat. Rec. (Hoboken) 2008 291 : 721 734.
27. Zeng W, Gouw AS, van den Heuvel MC et al. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization. Hepatology 2008 48 : 1517 1527.
28. Poon RT, Ho JW, Tong CS et al. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Br. J. Surg. 2004 91 : 1354 1360.
29. Poon RT, Ng IO, Lau C et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann. Surg. 2001 233 : 227 235.